Exocrine Pancreatic Carcinoma

  • M. Yamamoto
  • Y. Saitoh
  • P. Hermanek
Part of the UICC International Union Against Cancer / Union Internationale Contre le Cancer book series (UICCI)

Abstract

More than 90%–95% of malignant tumours of the pancreas are exocrine carcinomas. Surgical resection remains the only potentially curative approach, although the resectability is still low and the prognosis is still poor compared with cancer in other digestive organs. The median survival time for all diagnosed patients with exocrine pancreatic carcinoma is reported to be between 4 and 7 months [18,42, 66]; the overall 5-year survival rate is extremely low: in the older literature figures are under 1% [22]; recently, figures of l%–3% [18, 48] have been reported.

Keywords

Adenocarcinoma Pancreatitis Oncol Gall Peri 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alanen KA, Joensuu H, Klemi PJ, Nevalainen TJ (1990) Clinical significance of nuclear DNA content in pancreatic carcinoma. J Pathol 160: 313–320PubMedCrossRefGoogle Scholar
  2. 2.
    Allison DC, Bose KK, Hruban RH, Piantadosi S, Dooley WC, Boitnott K, Cameron JL (1991) Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduo-denectomy. Ann Surg 214: 648–656PubMedCrossRefGoogle Scholar
  3. 3.
    Baisch DC, Klöppel G, Reinke B (1990) DNA ploidy and cell-cycle analysis in pancreatic and ampullary carcinoma: flow cytometric study on formalin-fixed paraffin-embedded tissue. Virchows Arch [A] 417: 145–150CrossRefGoogle Scholar
  4. 4.
    Bakkevold KE, Kambestad B (1993) Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater - the prognostic factors influencing the long-term results. Eur J Surg Oncol 19: 147–161PubMedGoogle Scholar
  5. 5.
    Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H (1994) Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 81: 102–107PubMedCrossRefGoogle Scholar
  6. 6.
    Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds) (1992) AJCC: manual for staging of cancer, 4th edn. Lippincott, PhiladelphiaGoogle Scholar
  7. 7.
    Boettger T, Zech W, Sorger K, Junginger T (1990) Relevant factors in the prognosis of ductal pancreatic carcinoma. Acta Chir Scand 156: 781–788Google Scholar
  8. 8.
    Böttger TC, Störkel S, Wellek S, Stöckle M, Junginger T (1994) Factors influencing survival after resection of pancreatic cancer. Cancer 73: 63–73PubMedCrossRefGoogle Scholar
  9. 9.
    Bose KK, Allison DC, Hruban RH, Piantadosi S, Zahurak M, Dooley WC, Lin P, Cameron JL (1993) A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma. Cancer 71: 691–700PubMedCrossRefGoogle Scholar
  10. 10.
    Brennan MF, Kinsella TJ, Casper ES (1993) Cancer of the pancreas. In: de Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 4th edn. Lippincott, PhiladelphiaGoogle Scholar
  11. 11.
    Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Brittnot JK, Seidlerr AJ, Coleman J (1991) Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161: 120–124PubMedCrossRefGoogle Scholar
  12. 12.
    Connolly MM, Dawson PJ, Michelassi F, Moossa AR, Lowenstein F (1987) Survival in 1,001 patients with carcinoma of the pancreas. Ann Surg 206: 366–370PubMedCrossRefGoogle Scholar
  13. 13.
    Christ DW, Sitzmann JV, Cameron JL (1987) Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 206: 358–365CrossRefGoogle Scholar
  14. 14.
    Eskelinen M, Lipponen P (1992) A review of prognostic factors in human pancreatic adenocarcinoma. Cancer Detect Prev 16: 287–295PubMedGoogle Scholar
  15. 15.
    Eskelinen M, Lipponen P, Collan Y, Vainio O, Marin S, Alhava E (1991) Cancer of the pancreas: clinical stage, histological grade, surgical therapy and survival. Surg Res Commun 10: 9–14Google Scholar
  16. 16.
    Eskelinen M, Lipponen P, Marin S, Haapasalo H, Mäkinen K, Ahtola H, Puittinen J, Nuntinen P,Alhava E (1991) Prognostic factors in human pancreatic cancer, with special reference to quantitatve histology. Scand J Gastroenterol 26: 483–490PubMedCrossRefGoogle Scholar
  17. 17.
    Eskelinen M, Lipponen P, Marin S, Haapasalo H, Mäkinen K, Puittinen J, Alhava E, Nordling S (1992) DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer. Scand J Gastroenterol 27: 39–43PubMedCrossRefGoogle Scholar
  18. 18.
    Gall FP, Kessler H, Hermanek P (1991) Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 17: 173–181PubMedGoogle Scholar
  19. 19.
    Gall FP, Zirngibl H (1984) Chirurgische Therapie der Pankreastumoren. In: Gebhardt C (ed) Chirurgie des exokrinen Pankreas. Thieme, StuttgartGoogle Scholar
  20. 20.
    Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165: 68–73PubMedCrossRefGoogle Scholar
  21. 21.
    Grace PA, Pitt HA, Tompkins RK, Den Besten L, Longmire WP Jr (1986) Decreased morbidity and mortality after pancreaticoduodenectomy. Am J Surg 151: 141–149PubMedCrossRefGoogle Scholar
  22. 22.
    Gudjonsson B (1987) Cancer of the pancreas. 50 years of surgery. Cancer 60: 2284–2303PubMedCrossRefGoogle Scholar
  23. 23.
    Hermanek P (1991) Staging of exocrine pancreas carcinoma. Eur J Surg Oncol 17: 167–172PubMedGoogle Scholar
  24. 24.
    Hermanek P (1995) UICC TNM classification and stage grouping. In: Beger HG, Büchler MW, Schoenberg MH (eds) Cancer of the pancreas. Universitätsverlag, UlmGoogle Scholar
  25. 25.
    Hermanek P, Sobin LH (eds) (1992) UICC TNM classification of malignant tumours, 4th edn, 2nd rev. Universitatsverlag, UlmGoogle Scholar
  26. 26.
    Herrera MF, van Heerden JA, Katzmann JA, Weiland LH, Nagorney DM, Ilstrup D (1992) Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma. Ann Surg 215: 120–124PubMedCrossRefGoogle Scholar
  27. 27.
    Hohenberger W, Zirngibl H, Gall FP (1989) Pancreatic and periampullary carcinoma, In: Veronesi U, Arnesjo B, Burn I, Denis L, Mazzeo F (eds) Surgical oncology. A European handbook. Springer, Berlin Heidelberg New YorkGoogle Scholar
  28. 28.
    Hoorens A, Lemoine NR, McLellan E, Morohoshi T, Kamisawa T, Heitz PhU, Stamm B, Rüschoff J, Wiedenmann B, Klöppel G (1993) Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Surg Pathol 143: 685–698Google Scholar
  29. 29.
    Huguier M, Baumel H, Manderscheid J-C, Houry S, Fabre JM (1993) Surgical palliation for unresected cancer of the exocrine pancreas. Eur J Surg Oncol 19: 342–347PubMedGoogle Scholar
  30. 30.
    Ishikawa O (1993) What constitutes curative pancreatectomy for adenocarcinoma of the pancreas? Hepatogastroenterology 40: 414–417PubMedGoogle Scholar
  31. 31.
    Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, Kurada C, Iwanaga T (1992) Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 215: 231–236PubMedCrossRefGoogle Scholar
  32. 32.
    Japan Pancreas Society (1993) General rules for the study of the pancreatic cancer, 4rd edn. Kanehara, TokyoGoogle Scholar
  33. 33.
    Kayahara M, Nagakawa T, Kobayashi H, Mori K, Nakano T, Kadoya N, Ohta T, Ueno K, Miyazaki I (1992) Lymphatic flow in carcinoma of the head of the pancreas. Cancer 70: 2061–2066PubMedCrossRefGoogle Scholar
  34. 34.
    Kaiser MH, Barkin J, Maclntyre JM (1985) Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 56: 397–402CrossRefGoogle Scholar
  35. 35.
    Klöppel G, Lindenthal G, von Bülow M, Kern HF (1985) Histological and fine structural feature of pancreatic ductal adenocarcinomas in relation to growth and prognosis. Histopathology 9: 841–856PubMedCrossRefGoogle Scholar
  36. 36.
    Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Klöppel G (1993) The erb-B-3 gene in human pancreatic cancer. J Pathol 168: 269–273CrossRefGoogle Scholar
  37. 37.
    Lipponen PK, Eskelinen MJ, Collan Y, Marin S, Alhava E (1990) Volume-corrected mitotic index in human pancreatic cancer. Scand J Gastroenterol 25: 548–554PubMedCrossRefGoogle Scholar
  38. 38.
    Livingston EH, Welton ML, Reber HA (1991) Surgical treatment of pancreatic cancer. Int J Pancreatol 9: 153–157PubMedGoogle Scholar
  39. 39.
    Maekinen K, Eskelinen M, Lipponen P, Nuntinen P, Marin S, Alhava E (1993) Ag-Nors related to flow cytometry, morphometry and prognosis in patients with pancreatic cancer. Anticancer Res 13: 157–160Google Scholar
  40. 40.
    Manabe T, Ohsio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T (1989) Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64: 1132–1137PubMedCrossRefGoogle Scholar
  41. 41.
    Mannell A, Weiland LH, van Heerden JA, Ilstrup DM (1986) Factors influencing survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 203: 403–407PubMedCrossRefGoogle Scholar
  42. 42.
    Mohinddin M, Rosato F, Schuricht A, Barbot D, Biermann W, Cantor R (1994) Carcinoma of the pancreas - the Jefferson experience 1975–1988. Eur J Surg Oncol 20: 13–20Google Scholar
  43. 43.
    Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T (1993) Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 217: 138–143PubMedCrossRefGoogle Scholar
  44. 44.
    Nagakawa T, Kurachi M, Konishi K, Miyazaki I (1982) Translateral retroperitoneal approach in radical surgery for pancreatic carcinoma. Jpn J Surg 12: 229–233PubMedCrossRefGoogle Scholar
  45. 45.
    Nagakawa T, Konishi I,Ueno K, Ohta T, Akiyama T, Kanno M, Kayahara M, Miyazaki I (1991) The results and problems of extensive radical surgery for carcinoma of the head of the pancreas. Jpn J Surg 21: 262–267Google Scholar
  46. 46.
    Nagakawa T, Kayahara M, Ueno K, Konishi I, Ueda N, Miyazaki I (1992) A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer 69: 930–935PubMedCrossRefGoogle Scholar
  47. 47.
    Nakamori S, Ishikawa 0,0hhigashi H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T (1993) Expression of nucleoside diphosphate kinase /nm 23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 11: 151–158Google Scholar
  48. 48.
    National Cancer Institute (1990) Annual cancer statistics review: 1973–1988. National Institutes of Health Publ 90–2789, BethesdaGoogle Scholar
  49. 49.
    Neuberger TJ, Wade TP, Swope JT, Virgo KS, Johnson FE (1993) Palliative operations for pancreatic cancer in the hospitals of the U.S.Department of Veterans Affairs from 1987 to 1991. Am J Surg 166: 632–637PubMedCrossRefGoogle Scholar
  50. 50.
    Ohta T, Nagakawa T, Tsukioka Y, Mori K, Takeda T, Kayahara M, Ueno K, Fonseca L, Miyazaki I, Terada T (1993) Expression of argyrophilic nucleolar organizer regions in ductal adenocarcinoma of the pancreas and its relationship to prognosis. Int J Pancreatol 13: 193–200PubMedGoogle Scholar
  51. 51.
    Pancreatic Cancer Registration Committee of the Japan Pancreas Society (1993) Annual report of registered cases of pancreatic cancer in Japan (in Japanese). Japan Pancreas Society, TokyoGoogle Scholar
  52. 52.
    Porschen R, Remy U, Bevers G, Schauseil S, Hengeis K-J, Borchard F (1993) Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. Cancer 71: 3846–3850PubMedCrossRefGoogle Scholar
  53. 53.
    Reber HA (1990) Lymph node involvement as a prognostic factor in pancreatic cancer. Int J Pancreatol 7: 125–127PubMedGoogle Scholar
  54. 54.
    Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schröder S, Wurbs D, Klöppel G (1991) Intraductal mucin-hypersecreting neoplasms of the pancreas. Gastroenterology 101: 512–519PubMedGoogle Scholar
  55. 55.
    Roder JD, Siewert JR (1992) Analyse prognose-assoziierter Faktoren beim Pankreaskopf- und periampullären Carcinom. Chirurg 63: 410–415PubMedGoogle Scholar
  56. 56.
    Roder JD, Stein HJ, Hüttl W, Siewert JR (1992) Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 79: 152–155PubMedCrossRefGoogle Scholar
  57. 57.
    Roder JD, Nekarda H, Becker K, Rossmann A, Fink U, Siewert JR (1994) Ploidy and S-phase in resected ductal carcinoma of the pancreas: prognostic relevance. J Cancer Res Clin Oncol 120 [Suppl]: R73Google Scholar
  58. 58.
    Sharp KW, Ross CB, Halter SA, Morrison JG, Richards WO, Williams LF, Sawyers JL (1989) Pancreatoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery 105: 645–653PubMedGoogle Scholar
  59. 59.
    Tian F, Appert HE, Myles J, Howard JM (1992) Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma. Ann Surg 215: 350–355PubMedCrossRefGoogle Scholar
  60. 60.
    Trede M (1985) The surgical treatment of pancreatic carcinoma. Surgery 97: 28–35PubMedGoogle Scholar
  61. 61.
    Trede M, Schwall G, Saeger HD (1990) Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211: 447–458PubMedCrossRefGoogle Scholar
  62. 62.
    Trichopoulos D, Tzonou A, Kalapothaki V, Sparos L, Kremastinou T, Skoutari M (1990) Alpha 1-antitrypsin and survival in pancreatic cancer. Int J Cancer 45: 685–686PubMedCrossRefGoogle Scholar
  63. 63.
    Van Heerden JA, Mcllrath DC, Ilstrup DM, Weiland LH (1988) Total pancreatectomy for ductal adenocarcinoma of the pancreas: an update. World J Surg 12: 658–662PubMedCrossRefGoogle Scholar
  64. 64.
    Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161: 26–30PubMedCrossRefGoogle Scholar
  65. 65.
    Warshaw AL (1991) Implications of malignant-cell DNA content for treatment of patients with pancreatic cancer. Ann Surg 214: 645–647PubMedCrossRefGoogle Scholar
  66. 66.
    Warshaw AL, Swanson RS (1988) What’s new in general surgery? Pancreatic cancer in 1988: possibilities and probabilities. Ann Surg 208: 541–553PubMedCrossRefGoogle Scholar
  67. 67.
    Weger AR, Falkmer VG, Schwab G, Glaser K, Kemmler G, Bodner E, Auer E, Mikuz G (1990) Nuclear DNA distribution pattern of the parenchymal cells in adenocarcinomas of the pancreas and in chronic pancreatitis. Gastroenterology 99: 237–242PubMedGoogle Scholar
  68. 68.
    Willet CG, Lewanbrowski K, Warshaw AI, Efird J, Compton CC (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217: 144–148Google Scholar
  69. 69.
    Wittekind C (1993) Bedeutung von Tumorwachstum und -ausbreitung für die chirurgische Radikalität. Zentralbl Chir 118: 500–507PubMedGoogle Scholar
  70. 70.
    Yamaguchi K, Nishihara K, Kolodziejczyk P, Tsuneyoshi M (1992) Long survivors after pancreatoduodenectomy for pancreas head carcinoma. Aust N Z J Surg 62: 545–549PubMedCrossRefGoogle Scholar
  71. 71.
    Yamanaka Y (1992) The immunohistochemical expression of epidermal growth factors, epider¬mal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. J Nippon Med School 59: 51–57Google Scholar
  72. 72.
    Yamanaka Y, Friess H, Kobrin MS, Büchler M, Beger HG, Korc M (1993) Coexpression of epidermal growth factor receptors and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 13: 565–570PubMedGoogle Scholar
  73. 73.
    Yasuda H, Takada T, Uchiyana K, Hasegawa H (1993) Long-term prognosis and DNA ploidy pattern after pancreatoduodenectomy for cancer of the head of the pancreas. In: Takahasi T (ed) Recent advances in management of digestive cancers. Springer, Berlin Heidelberg New YorkGoogle Scholar
  74. 74.
    Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudacher C, Di Carlo V (1994) Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 73: 2930–2935PubMedCrossRefGoogle Scholar

Copyright information

© International Union Against Cancer, Geneva 1995

Authors and Affiliations

  • M. Yamamoto
  • Y. Saitoh
  • P. Hermanek

There are no affiliations available

Personalised recommendations